Jlohr Brain Health
  • Home
  • About Us
  • Brain Health Diagnoses
  • Resources on this Site
    • Drug Discount Services
    • With Each Diagnosis:
      • YouTube Video
      • Book from Library or Amazon
      • Support Group or Service
    • Tables for Patients:
      • Special Education
      • Social Security Disability Income
      • School Aid
    • Tables for Patients or Professionals
      • Overview of 9 Aspects of this Diagnosis
      • DSM-5’s First Pages and ICD-10’s Billing Codes
  • Medical & Educational Downloads
  • Contact Us
Select Page

Oleic acid Enriched Leciplexes as Novel Mucoadhesive Cationic Nanocarriers of Agomelatine for Glaucoma Treatment

by jlohrconsulting | Oct 25, 2025 | Uncategorized

AAPS PharmSciTech. 2025 Oct 24;27(1):4. doi: 10.1208/s12249-025-03250-0. ABSTRACT Agomelatine (AGO) is a dual action drug. Being serotonin receptor antagonist, AGO is orally administered for depression treatment. Here in, AGO was used for intraocular pressure...

Proof-of-concept for a randomized factorial design strategy to build a complex online support program for cancer survivors with psychiatric symptoms: the IN-FACT-0 feasibility trial

by jlohrconsulting | Oct 25, 2025 | Uncategorized

J Cancer Surviv. 2025 Oct 25. doi: 10.1007/s11764-025-01905-2. Online ahead of print. ABSTRACT PURPOSE: Internet-delivered cognitive behavioral therapies and lifestyle interventions are promising for reducing psychiatric symptoms in cancer survivors, but little is...

Indigenous youth mental health: an ecological approach to understanding risk and protective factors for Māori youth in Aotearoa New Zealand

by jlohrconsulting | Oct 25, 2025 | Uncategorized

BMC Public Health. 2025 Oct 24;25(1):3600. doi: 10.1186/s12889-025-24845-z. ABSTRACT BACKGROUND: Māori (Indigenous) youth of Aotearoa New Zealand are experiencing widening inequities in mental health when compared to Pākehā (New Zealand European/other...

Gas station heroin- tianeptine and its impact: a systematic review and exploratory analysis

by jlohrconsulting | Oct 25, 2025 | Uncategorized

BMC Public Health. 2025 Oct 24;25(1):3591. doi: 10.1186/s12889-025-24666-0. ABSTRACT BACKGROUND: Tianeptine, a drug approved in some countries for the treatment of major depressive disorder, has raised significant public health concerns due to its potential for misuse...

Identification of clinically meaningful, overlapping obstructive respiratory disease subtypes via data-driven approaches in a primary care population

by jlohrconsulting | Oct 25, 2025 | Uncategorized

BMC Pulm Med. 2025 Oct 24;25(1):487. doi: 10.1186/s12890-025-03953-x. ABSTRACT BACKGROUND: Obstructive respiratory conditions, including asthma, bronchiectasis, and chronic obstructive pulmonary disease (COPD), are increasingly recognised as heterogeneous syndromes...
« Older Entries
Next Entries »

Recent Posts

  • Dissociative Drug-Induced Anxiety
  • Associations in intentions to use anabolic-androgenic steroids among non-consuming boys and men with probable eating disorders and muscle dysmorphia
  • Assessing schema modes for eating disorders and their association with personality traits: validation of the English version of the short form of the schema modes inventory for eating disorders (EN-SMI-ED-SF)
  • Associations in intentions to use anabolic-androgenic steroids among non-consuming boys and men with probable eating disorders and muscle dysmorphia
  • Assessing schema modes for eating disorders and their association with personality traits: validation of the English version of the short form of the schema modes inventory for eating disorders (EN-SMI-ED-SF)

Recent Comments